tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CANF Stock Latest News

Upcoming Stock Splits This Week (January 5 to January 9) – Stay Invested
Market NewsUpcoming Stock Splits This Week (January 5 to January 9) – Stay Invested
7d ago
ICU
TRT
Can-Fite BioPharma Secures Brazilian Patent for A3AR-Based Sexual Dysfunction Therapy
PremiumCompany Announcements
Can-Fite BioPharma Secures Brazilian Patent for A3AR-Based Sexual Dysfunction Therapy
13d ago
6K
CANF
Can-Fite BioPharma downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
Can-Fite BioPharma downgraded to Hold from Buy at D. Boral Capital
18d ago
CANF
Can-Fite BioPharma Sets 1-for-3,000 Reverse Share Split and ADS Ratio Change Effective Early January 2026
PremiumCompany Announcements
Can-Fite BioPharma Sets 1-for-3,000 Reverse Share Split and ADS Ratio Change Effective Early January 2026
19d ago
6K
CANF
Can-Fite BioPharma announces 1-for-3,000 reverse split, ratio change
PremiumThe Fly
Can-Fite BioPharma announces 1-for-3,000 reverse split, ratio change
19d ago
CANF
Can-Fite BioPharma Updates on Clinical Trials and Financials
PremiumCompany AnnouncementsCan-Fite BioPharma Updates on Clinical Trials and Financials
26d ago
6K
CANF
Can-Fite BioPharma provides clinical, financial update
Premium
The Fly
Can-Fite BioPharma provides clinical, financial update
26d ago
CANF
Can-Fite BioPharma to participate in BioFIT 2025
Premium
The Fly
Can-Fite BioPharma to participate in BioFIT 2025
2M ago
CANF
Can-Fite BioPharma Adjusts Warrant Terms to Enhance Market Appeal
PremiumCompany Announcements
Can-Fite BioPharma Adjusts Warrant Terms to Enhance Market Appeal
2M ago
6K
CANF
Can-Fite’s CF602 Secures Patent in Brazil for Erectile Dysfunction Treatment
PremiumCompany Announcements
Can-Fite’s CF602 Secures Patent in Brazil for Erectile Dysfunction Treatment
2M ago
6K
CANF
Can-Fite BioPharma receives Notice of Allowance from Brazil for patent on CF602
PremiumThe Fly
Can-Fite BioPharma receives Notice of Allowance from Brazil for patent on CF602
2M ago
CANF
CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CANF
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
B
HD
Why Is Can-Fite BioPharma Stock (CANF) Up Today?
Premium
Market News
Why Is Can-Fite BioPharma Stock (CANF) Up Today?
2M ago
CANF
Can-Fite Achieves 9-Year Survival Milestone in Liver Cancer Treatment
Premium
Company Announcements
Can-Fite Achieves 9-Year Survival Milestone in Liver Cancer Treatment
2M ago
6K
CANF
Can-Fite announces 9-year survival with complete cure with Namodenoson
PremiumThe Fly
Can-Fite announces 9-year survival with complete cure with Namodenoson
2M ago
CANF
Can-Fite BioPharma Shareholders Approve Key Proposals
PremiumCompany Announcements
Can-Fite BioPharma Shareholders Approve Key Proposals
2M ago
6K
CANF
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
PremiumRatings
Buy Rating for Can-Fite BioPharma: Promising A3AR Agonists in Psoriasis and Liver Cancer with Strong Safety Profile
2M ago
CANF
Can-Fite BioPharma assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Can-Fite BioPharma assumed with a Buy at H.C. Wainwright
2M ago
CANF
Can-Fite BioPharma Reschedules Shareholder Meeting Due to Lack of Quorum
PremiumCompany AnnouncementsCan-Fite BioPharma Reschedules Shareholder Meeting Due to Lack of Quorum
2M ago
6K
CANF
Can-Fite BioPharma’s Phase 3 Psoriasis Study: A Potential Game Changer?
Premium
Company Announcements
Can-Fite BioPharma’s Phase 3 Psoriasis Study: A Potential Game Changer?
3M ago
CANF
Can-Fite BioPharma’s Promising Phase 3 Trial for Liver Cancer Treatment
Premium
Company Announcements
Can-Fite BioPharma’s Promising Phase 3 Trial for Liver Cancer Treatment
3M ago
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >